Clinical Trial Update: Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients [NA]

View source ↗

Summary

This clinical trial update shows that a study testing minimal residual disease for early detection of recurrence in patients with resectable stage II-IV colorec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: Resectable Colorectal Carcinoma, Stage II Colorectal Cancer AJCC v8 | NA | Status: RECRUITING